Can short-acting interferon be continued after being used for 4 years?
Whether short-acting interferon can be continued after four years of use depends on the disease control status and the body's tolerance. If the condition remains stable without serious adverse reactions, continuation under medical guidance may be appropriate. However, if there is no improvement in the disease or significant intolerance occurs, treatment should be stopped and the therapeutic plan adjusted. Detailed analysis is as follows:

If the disease is well controlled after treatment, relevant indicators remain within the ideal range, and only mild local reactions occur—without issues such as bone marrow suppression or severe liver or kidney damage—and overall tolerance is good, continued use may be considered following physician evaluation to consolidate therapeutic effects.
If the disease remains uncontrolled after four years of treatment, or if intolerance issues such as persistent fatigue, abnormal bone marrow hematopoiesis, or impaired liver or kidney function arise, continuing the medication may increase physical burden and potentially compromise treatment outcomes. In such cases, treatment should be promptly discontinued and an alternative therapy initiated.
In daily management, strictly follow medical instructions regarding medication; do not adjust dosage or discontinue treatment without consultation. Regularly recheck relevant indicators to monitor disease progression and physical condition. Maintain a regular作息 (daily routine), avoid overexertion, and enhance nutritional intake to improve bodily tolerance.